Smart insulin is used to deliver insulin into diabetic patients. Increase in demand for self-injection devices, rise in prevalence of diabetes, and accuracy in dosage delivery of insulin are expected to drive the market growth. The market is expected to witness an exponential growth during the forecast period, owing to benefits of using these advanced devices over conventional products and increase in healthcare expenses. Moreover, rise in the incidences of diabetes globally and increase in diabetic patients are expected to boost the market growth. As per data published by the NCBI (National Center for Biotechnology Information) in 2016, six million people with diabetes used insulin either alone or in combination with an oral medication. However, lack of awareness, cost restrains in developing regions, and less variability in products are expected to hinder the market growth. Development of affordable products with fewer side effects and presence of undiagnosed diabetic patients globally are expected to provide opportunities for the market growth.
The smart insulin or glucose responsive insulin market is segmented on the basis of type, disease, delivery devices, and region. By type, it is divided into rapid-acting, intermediate-acting, long-acting, short-acting and pre-mixed type. On the basis of disease, it is bifurcated into Type 1 and Type 2 diabetes. On the basis of delivery devices, it is classified into smart insulin pen and smart insulin pump.
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the majority of the market share in 2019, and is anticipated to continue this trend during the forecast period. North America holds a dominant share in the global Smart Insulin or Glucose Responsive Insulin market, because well-developed supply-side infrastructure, rapid acceptance of innovative technologies, and adequate reimbursements have fuelled the growth of the North American smart insulin or glucose responsive insulin market. Asia Pacific is expected to continue the trend throughout the forecast period, because growth is increase in diabetic population across the region.
Key Market Segments
By Delivery Devices
- Smart Insulin Pen
- Smart Insulin Pump
- Tethered Insulin Pumps
- Insulin Patch Pumps
By Disease
- Type 1 Diabetes
- Type 2 Diabetes
By Type
- Rapid Acting
- Intermediate Acting
- Long Acting
- Short Acting
- Premixed Type
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
List of Key Players Profiled in the Report
- CeQur
- Diamesco Co
- Eli lily and Company
- F. Hoffmann-La Roche AG
- Insulet Corporation
- Medtronic Plc
- Novo Nordisk A/S.
- Sanofi
- Zealand Pharma
What is the estimated value of the Global Smart Insulin Or Glucose Responsive Insulin Market?
What is the growth rate of the Global Smart Insulin Or Glucose Responsive Insulin Market?
What is the forecasted size of the Global Smart Insulin Or Glucose Responsive Insulin Market?
Report Attribute | Details |
---|---|
No. of Pages | 231 |
Published | August 2020 |
Forecast Period | 2019 - 2027 |
Estimated Market Value ( USD | $ 2773.73 million |
Forecasted Market Value ( USD | $ 6174.3 million |
Compound Annual Growth Rate | 10.5% |
Regions Covered | Global |
Table of Contents
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...